CRPC w/ Bone Metastases
Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases
November 2, 2016
Cancer Cell Colonisation in the Bone Microenvironment
November 2, 2016
Radium-223 Therapy for Patients with Metastatic Castrate-Resistant Prostate Cancer: An Update on Literature with Case Presentation
November 2, 2016
Radium-223: Insight and Perspectives in Bone-metastatic Castration-resistant Prostate Cancer
November 1, 2016
Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone
November 1, 2016
Current therapeutic options targeting bone metastasis in metastatic castration resistant prostate cancer
October 3, 2016
2016 ESMO Congress - Bayer to Showcase Latest Oncology Research
September 28, 2016
Hematologic Safety of Radium-223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA Trial
September 12, 2016
Sunitinib maintenance therapy after response to docetaxel in metastatic castration resistant prostate cancer (mCRPC)
August 31, 2016
How I do it: Prescribing abiraterone acetate for metastatic castration resistant prostate cancer
August 25, 2016